Iron shot boosts heart Patients' stamina, study hopes
NCT ID NCT04945707
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study tests whether a single dose of intravenous iron (ferric derisomaltose) can improve exercise capacity in people with heart failure with preserved ejection fraction who also have iron deficiency. About 66 adults will receive either the iron infusion or a placebo, and their oxygen use during exercise will be measured after 12 weeks. The goal is to see if correcting iron deficiency helps them feel less tired and do more physical activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can shedding pounds reboot the Heart's exercise engine?
- Iron deficiency hidden by inflammation: a new test may see through it
- Iron infusions put to the test for heart failure stamina
- Keto vs. Low-Fat: which diet helps heart failure patients move better?
- Zapping lung nerves could ease heart Failure-Related high blood pressure
- Stiff arteries may hold key to heart failure progression